Our Pipeline

Using our platforms, we are currently advancing 4 programs that will revolutionize how ADCs will be designed.

Program
Indications
Discovery
Lead Optimisation & Preclinical
Phase I

VLN1

Unannounced

CRC

Pan-cancer

NSCLC, GYN, Solid

VLN4

VLN3

VLN2

Discovery

VLN3

Pan-cancer

VLN4

Unannounced

Lead Optimisation & Preclinical

VLN2

CRC

VLN1

NSCLC, GYN, Solid

Work with Valink

Reach out on LinkedIn or connect@valinktx.com to learn more about our assets or to explore opportunities to collaborate on our discovery engine.

Contact us

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
United States

Valink Therapeutics Inc
One Broadway,
Cambridge,
Massachusetts,
02142

United Kingdom

Valink Therapeutics Ltd
Imperial I-Hub,

84 Wood Lane,

London,

W12 0BZ